Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Soleno Therapeutics (SLNO) Return on Sales (2016 - 2025)

Soleno Therapeutics (SLNO) has disclosed Return on Sales for 6 consecutive years, with 0.47% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales changed N/A to 0.47% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.13%, a N/A change, with the full-year FY2025 number at 0.11%, down 76115.0% from a year prior.
  • Return on Sales was 0.47% for Q4 2025 at Soleno Therapeutics, up from 0.38% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 32.16% in Q1 2025 to a low of 0.38% in Q3 2025.